Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
2csn | CKI | Casein kinase I homolog 1 | 2.7.11.1 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
2csn | CKI | Casein kinase I homolog 1 | 2.7.11.1 | 1.000 | |
2cmw | OLP | Casein kinase I isoform gamma-1 | 2.7.11.1 | 0.543 | |
2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.538 | |
3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.538 | |
1csn | ATP | Casein kinase I homolog 1 | 2.7.11.1 | 0.534 | |
4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.532 | |
2izu | P01 | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.526 | |
3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.524 | |
1eh4 | IC1 | Casein kinase I homolog 1 | 2.7.11.1 | 0.521 | |
2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.520 | |
4enx | Z20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.520 | |
4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.520 | |
4hni | 16W | Casein kinase I isoform epsilon | 2.7.11.1 | 0.518 | |
4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.518 | |
4a06 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.516 | |
4qna | X11 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.516 | |
3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.515 | |
3d7t | STU | Tyrosine-protein kinase CSK | / | 0.513 | |
4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.513 | |
4q5j | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.513 | |
1py5 | PY1 | TGF-beta receptor type-1 | 2.7.11.30 | 0.512 | |
4bbe | 3O4 | Tyrosine-protein kinase JAK2 | / | 0.512 | |
2wou | ZZF | TGF-beta receptor type-1 | 2.7.11.30 | 0.511 | |
1w0x | OLO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.510 | |
3tkh | 07S | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.510 | |
3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.510 | |
4iwo | 1H4 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.510 | |
4eny | J19 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.509 | |
4dit | 0KD | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.508 | |
2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.507 | |
3uyt | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.507 | |
4o0w | ADN | Aurora kinase A | 2.7.11.1 | 0.507 | |
1q41 | IXM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.506 | |
4g17 | 0VN | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.506 | |
4lyn | 1YG | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.506 | |
3ckx | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.505 | |
2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.503 | |
3l1s | Z92 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.503 | |
2pe0 | 39Z | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.500 | |
3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.500 | |
1oky | STU | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.499 | |
1u54 | ACP | Activated CDC42 kinase 1 | / | 0.499 | |
2btr | U73 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.498 | |
2pe2 | 464 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.498 | |
2pvl | P55 | Casein kinase II subunit alpha | 2.7.11.1 | 0.498 | |
3a7h | ATP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.498 | |
4hge | 15V | Tyrosine-protein kinase JAK2 | / | 0.498 | |
4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.498 | |
1m2r | MNY | Casein kinase II subunit alpha | 2.7.11.1 | 0.497 | |
2c3l | IDZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.497 | |
2cch | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.497 | |
2cdz | 23D | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.497 | |
4k18 | 1OB | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.497 | |
1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 | 0.496 | |
1wvx | BD4 | Death-associated protein kinase 1 | 2.7.11.1 | 0.496 | |
2pe1 | 517 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.496 | |
4bl1 | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.496 | |
4cki | ADN | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.496 | |
1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.495 | |
4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.495 | |
2vv9 | IM9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.494 | |
1pxo | CK7 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.493 | |
5auv | AGI | Death-associated protein kinase 1 | 2.7.11.1 | 0.493 | |
3bqr | 4RB | Death-associated protein kinase 3 | / | 0.492 | |
3js2 | VM1 | Fibroblast growth factor receptor 1 | / | 0.492 | |
3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.492 | |
4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.492 | |
2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.491 | |
3f7z | 34O | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.491 | |
4ft3 | H1K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.491 | |
1q5k | TMU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.490 | |
1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.490 | |
4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.490 | |
3hzt | J60 | Calmodulin-like domain protein kinase isoform 3 | / | 0.489 | |
3r73 | X87 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.489 | |
2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.488 | |
4fv6 | E57 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.488 | |
4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.488 | |
4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.488 | |
2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.487 | |
3lpb | NVB | Tyrosine-protein kinase JAK2 | / | 0.487 | |
3sc1 | 3S1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.487 | |
4acd | GR9 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.487 | |
4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.487 | |
2pvn | P63 | Casein kinase II subunit alpha | 2.7.11.1 | 0.486 | |
3ggf | GVD | Serine/threonine-protein kinase 26 | / | 0.486 | |
4btj | ATP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.486 | |
4hgs | 15G | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.486 | |
2clq | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.485 | |
2izt | 23D | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.485 | |
3t8o | ATP | Rhodopsin kinase | / | 0.485 | |
4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.485 | |
3r2b | 05B | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.484 | |
4l3l | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.484 | |
5ar4 | SB2 | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.484 | |
2x8i | X8I | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.483 | |
3s2p | PMU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.483 | |
4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.483 | |
4fv5 | EK9 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.483 | |
4im2 | BX7 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.483 | |
1w8c | N69 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.482 | |
2c6l | DT4 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.482 | |
3ofm | 4B0 | Casein kinase II subunit alpha' | 2.7.11.1 | 0.482 | |
4acc | 7YG | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.482 | |
4ez5 | 0RS | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.482 | |
4fv2 | EK5 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.482 | |
4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.482 | |
1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.481 | |
2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.481 | |
2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.481 | |
3ezr | EZR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.481 | |
3iok | 1P6 | Tyrosine-protein kinase JAK2 | / | 0.481 | |
3qcy | 3Q3 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.481 | |
3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.481 | |
5dt0 | SKE | Aurora kinase A | 2.7.11.1 | 0.481 | |
3nuu | JOZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.480 | |
4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.480 | |
2z7q | ACP | Ribosomal protein S6 kinase alpha-1 | 2.7.11.1 | 0.479 | |
3amb | VX6 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.479 | |
4aqc | 88A | Tyrosine-protein kinase JAK2 | / | 0.479 | |
4ek6 | 10K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.479 | |
4g16 | 0VM | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.479 | |
4rqk | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.479 | |
1g5s | I17 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.478 | |
2phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.478 | |
3pls | ANP | Macrophage-stimulating protein receptor | 2.7.10.1 | 0.478 | |
3umw | 596 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.478 | |
4fv3 | EK6 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.478 | |
4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.478 | |
4ix6 | ADP | Uncharacterized protein | / | 0.478 | |
2c4g | 514 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.477 | |
2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.477 | |
2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.477 | |
3qcs | 3Q1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.477 | |
3rwp | ABQ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.477 | |
4fsu | HK5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.477 | |
2ayp | 43A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.476 | |
2izs | BRQ | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.476 | |
3gu6 | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.476 | |
3rvg | 17P | Tyrosine-protein kinase JAK2 | / | 0.476 | |
3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.476 | |
4o0s | ADN | Aurora kinase A | 2.7.11.1 | 0.476 | |
4wbo | ANW | Rhodopsin kinase | / | 0.476 | |
1fvv | 107 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.475 | |
1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.475 | |
2iw9 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.475 | |
2vto | LZ8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.475 | |
3q9x | EMO | Casein kinase II subunit alpha | 2.7.11.1 | 0.475 | |
3r1y | X76 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.475 | |
3r71 | X86 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.475 | |
3r7u | X96 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.475 | |
4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.475 | |
4oti | MI1 | Serine/threonine-protein kinase N1 | / | 0.475 | |
2vtq | LZA | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.474 | |
2x2l | X2L | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.474 | |
3cgf | JNF | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.474 | |
3nyn | SGV | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.474 | |
3rpo | 24Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.474 | |
3v5j | 0F2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.474 | |
3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.474 | |
4c34 | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.474 | |
4fkt | 48K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.474 | |
4iwq | 1FV | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.474 | |
4mvf | STU | Calcium-dependent protein kinase 2 | 2.7.11.1 | 0.474 | |
1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.473 | |
1mru | AGS | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.473 | |
1okz | UCN | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.473 | |
1pkd | UCN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.473 | |
1y91 | CT9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.473 | |
1ykr | 628 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.473 | |
2in6 | 839 | Wee1-like protein kinase | 2.7.10.2 | 0.473 | |
2w17 | I19 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.473 | |
2wti | WTI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.473 | |
3et7 | 349 | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.473 | |
3ezv | EZV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.473 | |
3oro | AGS | Serine/threonine protein kinase | / | 0.473 | |
4agu | D15 | Cyclin-dependent kinase-like 1 | / | 0.473 | |
4aoj | V4Z | High affinity nerve growth factor receptor | 2.7.10.1 | 0.473 | |
4fg9 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.473 | |
4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.473 | |
1om1 | IQA | Casein kinase II subunit alpha | 2.7.11.1 | 0.472 | |
1v1k | 3FP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.472 | |
3at4 | CCK | Casein kinase II subunit alpha | 2.7.11.1 | 0.472 | |
3rni | 21Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.472 | |
4acg | 6LQ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.472 | |
5ack | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.472 | |
1h0w | 207 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
1ny3 | ADP | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.471 | |
2biy | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.471 | |
2bts | U32 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
2nru | T12 | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.471 | |
2pvh | P19 | Casein kinase II subunit alpha | 2.7.11.1 | 0.471 | |
2wmr | ZYR | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.471 | |
2x6d | X6D | Aurora kinase A | 2.7.11.1 | 0.471 | |
2xck | MH4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.471 | |
3hrc | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.471 | |
3lfq | A28 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.471 | |
3qcq | 3Q0 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.471 | |
3tnw | F18 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
4dgn | LU2 | Casein kinase II subunit alpha | 2.7.11.1 | 0.471 | |
4l9i | 8PR | Rhodopsin kinase | / | 0.471 | |
3r7y | Z04 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.470 | |
4im0 | 1FV | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.470 | |
4jaj | XU1 | Aurora kinase A | 2.7.11.1 | 0.470 | |
4nj3 | 2KD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.470 | |
4oh4 | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.470 | |
4y93 | 746 | Tyrosine-protein kinase | / | 0.470 | |
5d12 | G97 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.470 | |
5dr9 | SKE | Aurora kinase A | 2.7.11.1 | 0.470 | |
1gii | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.469 | |
1vyz | N5B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.469 | |
2a0c | CK9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.469 | |
3r7i | X9I | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.469 | |
4bgh | 3I6 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.469 | |
4dgo | 0JW | Casein kinase II subunit alpha | 2.7.11.1 | 0.469 | |
4eut | BX7 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.469 | |
4k8a | K8A | Focal adhesion kinase 1 | 2.7.10.2 | 0.469 | |
4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.469 | |
2vtj | LZ4 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.468 | |
2vz6 | FEF | Calcium/calmodulin-dependent protein kinase type II subunit alpha | 2.7.11.17 | 0.468 | |
2wmq | ZYQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.468 | |
3c4z | ADP | Rhodopsin kinase | / | 0.468 | |
3cd3 | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.468 | |
3igo | ANP | Calmodulin-domain protein kinase 1, putative | / | 0.468 | |
3nux | 3NV | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.468 | |
3vw6 | IM6 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.468 | |
4anx | 534 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.468 | |
4cd0 | AWJ | ALK tyrosine kinase receptor | 2.7.10.1 | 0.468 | |
4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.468 | |
4gfg | 0XF | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.468 | |
5av2 | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.468 | |
1di8 | DTQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
2chl | DKI | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.467 | |
2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.467 | |
2ijm | ADP | Focal adhesion kinase 1 | 2.7.10.2 | 0.467 | |
3kga | LX9 | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.467 | |
3nun | JMZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.467 | |
3we4 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.467 | |
3wi6 | YRZ | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.467 | |
4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.467 | |
4gv1 | 0XZ | RAC-alpha serine/threonine-protein kinase | 2.7.11.1 | 0.467 | |
4qmz | B49 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.467 | |
4rqv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.467 | |
5e8y | STU | TGF-beta receptor type-2 | 2.7.11.30 | 0.467 | |
1pxl | CK4 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.466 | |
2brg | DFY | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.466 | |
2vtp | LZ9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.466 | |
2x1n | X1N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.466 | |
3lxi | CAM | Cytochrome P450 | / | 0.466 | |
3she | I85 | MAP kinase-activated protein kinase 3 | 2.7.11.1 | 0.466 | |
4anm | WUL | Casein kinase II subunit alpha | 2.7.11.1 | 0.466 | |
4cdm | FO1 | Deoxyribodipyrimidine photolyase | / | 0.466 | |
4l3j | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.466 | |
1h1r | 6CP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.465 | |
1u59 | STU | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.465 | |
1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.465 | |
2i40 | BLZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.465 | |
3gb2 | G3B | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.465 | |
4afj | SJJ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.465 | |
4fkg | 4CK | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.465 | |
4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.465 | |
4l49 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.465 | |
4qmt | H1N | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.465 | |
1nvr | STU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.464 | |
1oi9 | N20 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
2etr | Y27 | Rho-associated protein kinase 1 | 2.7.11.1 | 0.464 | |
2h96 | 893 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.464 | |
2pvm | P29 | Casein kinase II subunit alpha | 2.7.11.1 | 0.464 | |
2r7b | 253 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.464 | |
2uzo | C62 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
2z2w | 770 | Wee1-like protein kinase | 2.7.10.2 | 0.464 | |
3ort | AGS | Serine/threonine protein kinase | / | 0.464 | |
3qd3 | 3Q5 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.464 | |
3qd4 | 3Q6 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.464 | |
4bcq | TJF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
4ct2 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.464 | |
4fsn | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.464 | |
4j99 | ACP | Fibroblast growth factor receptor 2 | / | 0.464 | |
1z5m | LI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.463 | |
1zrz | BI1 | Protein kinase C iota type | 2.7.11.13 | 0.463 | |
2c6i | DT1 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
2fvd | LIA | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
3bhy | 7CP | Death-associated protein kinase 3 | / | 0.463 | |
3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.463 | |
3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.463 | |
4e6d | 0NU | Tyrosine-protein kinase JAK2 | / | 0.463 | |
4kb8 | 1QO | Casein kinase I isoform delta | 2.7.11.1 | 0.463 | |
4mq2 | 2C4 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 2.7.12.1 | 0.463 | |
4xlv | ACP | Insulin receptor | 2.7.10.1 | 0.463 | |
1e9h | INR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
1yvj | 4ST | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.462 | |
2brh | DFW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
2brn | DF1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
2cgu | 3A3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.462 | |
2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
2ghm | LIC | Mitogen-activated protein kinase 14 | / | 0.462 | |
2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.462 | |
2xbj | XBJ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.462 | |
3qx2 | X63 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
3zep | 1NX | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.462 | |
4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.462 | |
4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
4g1w | G1W | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.462 | |
1q3w | ATU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.461 | |
1stc | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.461 | |
1uu3 | LY4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.461 | |
2uw0 | GVK | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.461 | |
2wih | P48 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.461 | |
3kn5 | ANP | Ribosomal protein S6 kinase alpha-5 | 2.7.11.1 | 0.461 | |
3qxo | X65 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
4fki | 09K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
4jqe | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.461 | |
4kbc | 1QJ | Casein kinase I isoform delta | 2.7.11.1 | 0.461 | |
4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.461 | |
5aux | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.461 | |
5dr6 | SKE | Aurora kinase A | 2.7.11.1 | 0.461 | |
1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.460 | |
2b7a | IZA | Tyrosine-protein kinase JAK2 | / | 0.460 | |
2e9u | A25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.460 | |
2wtc | VGM | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.460 | |
3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.460 | |
3le6 | 2BZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
3llt | ANP | Protein serine/threonine kinase-1 | / | 0.460 | |
3mfs | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.460 | |
3mvh | WFE | RAC-alpha serine/threonine-protein kinase | 2.7.11.1 | 0.460 | |
3rak | 03Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
4bfm | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.460 | |
4dgm | AGI | Casein kinase II subunit alpha | 2.7.11.1 | 0.460 | |
4f63 | 0S7 | Fibroblast growth factor receptor 1 | / | 0.460 | |
4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.460 | |
4kik | KSA | Inhibitor of nuclear factor kappa-B kinase subunit beta | 2.7.11.10 | 0.460 | |
5auw | QUE | Death-associated protein kinase 1 | 2.7.11.1 | 0.460 | |
5av4 | GEN | Death-associated protein kinase 1 | 2.7.11.1 | 0.460 | |
5csh | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.460 | |
1aq1 | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
1j1b | ANP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.459 | |
1oiy | N41 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
1uvr | BI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.459 | |
2obj | VRV | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.459 | |
3qyw | 6PB | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.459 | |
3v8t | 477 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.459 | |
4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.459 | |
1j1c | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.458 | |
2io6 | 330 | Wee1-like protein kinase | 2.7.10.2 | 0.458 | |
2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.458 | |
3igg | EFQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
3jxw | LXG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.458 | |
3my5 | RFZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
3qqk | X02 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
4fks | 46K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
4ftj | H8K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.458 | |
4ftr | 5HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.458 | |
1ke6 | LS2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
2chz | 093 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.457 | |
2cke | IQU | Death-associated protein kinase 2 | / | 0.457 | |
3cqw | CQW | RAC-alpha serine/threonine-protein kinase | 2.7.11.1 | 0.457 | |
3emg | 685 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.457 | |
3rmf | 20Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
3umx | Q18 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.457 | |
3vf9 | 477 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.457 | |
4ft0 | HK9 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.457 | |
4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.457 | |
4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.457 | |
1o6y | ACP | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.456 | |
1p2a | 5BN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
1u5r | ATP | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.456 | |
2c47 | 5ID | Casein kinase I isoform gamma-2 | / | 0.456 | |
2hck | QUE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.456 | |
2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.456 | |
3ddp | RC8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
3ncz | 3NC | Rho-associated protein kinase 1 | 2.7.11.1 | 0.456 | |
4bch | T7Z | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.456 | |
4bie | IE6 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.456 | |
4dea | NHI | Aurora kinase A | 2.7.11.1 | 0.456 | |
4ekl | 0RF | RAC-alpha serine/threonine-protein kinase | 2.7.11.1 | 0.456 | |
4fsm | HK1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.456 | |
4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.456 | |
4mq1 | 2C3 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 2.7.12.1 | 0.456 | |
4yhj | AN2 | G protein-coupled receptor kinase 4 | 2.7.11.16 | 0.456 | |
1pye | PM1 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.455 | |
2xik | J60 | Serine/threonine-protein kinase 25 | 2.7.11.1 | 0.455 | |
2ydj | YDJ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
3c4w | ATP | Rhodopsin kinase | / | 0.455 | |
3lmg | ANP | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.455 | |
3zmm | F9J | Tyrosine-protein kinase JAK2 | / | 0.455 | |
4bco | T6Q | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
4krc | AGS | Cyclin-dependent protein kinase PHO85 | 2.7.11.22 | 0.455 | |
1h1w | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.454 | |
2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.454 | |
3bgq | VX2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.454 | |
3qqf | X07 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
4fl2 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.454 | |
4ftu | 7HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
4gj2 | 0XH | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.454 | |
4jrn | ANP | Rhoptry kinase family protein | / | 0.454 | |
4n70 | 2HX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.454 | |
2f2c | AP9 | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.453 | |
2uzt | SS3 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.453 | |
2vu3 | LZE | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
3c4x | ATP | Rhodopsin kinase | / | 0.453 | |
3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.453 | |
3jy0 | LYG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.453 | |
3lfs | A07 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
3qzh | X69 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
3rk5 | 07Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
4ct1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.453 | |
4gub | 0Y4 | Casein kinase II subunit alpha | 2.7.11.1 | 0.453 | |
4hvb | 19P | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.453 | |
4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.453 | |
2uxp | CLM | HTH-type transcriptional regulator TtgR | / | 0.452 | |
3be9 | P04 | Casein kinase II subunit alpha | 2.7.11.1 | 0.452 | |
3cy2 | MB9 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.452 | |
3eyh | IZA | Tyrosine-protein kinase JAK1 | / | 0.452 | |
3kkv | B99 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.452 | |
4btm | F8E | Tau-tubulin kinase 1 | 2.7.11.1 | 0.452 | |
4jik | 1KO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
4jr7 | GNP | Casein kinase II subunit alpha | 2.7.11.1 | 0.452 | |
4l44 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.452 | |
4rrv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.452 | |
1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.451 | |
1ydr | IQP | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.451 | |
2c6o | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
2euf | LQQ | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.451 | |
2uzu | L20 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.451 | |
2vtr | LZB | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
3du8 | 553 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.451 | |
3r04 | UNQ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.451 | |
3rm6 | 18Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 0.451 | |
4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
4fhk | 0U0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.451 | |
4kbk | 1QG | Casein kinase I isoform delta | 2.7.11.1 | 0.451 | |
5cno | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.451 | |
1bws | NDP | GDP-L-fucose synthase | / | 0.450 | |
1m2q | MNX | Casein kinase II subunit alpha | 2.7.11.1 | 0.450 | |
1t87 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.450 | |
1v35 | NAI | Enoyl-ACP reductase | / | 0.450 | |
1vyw | 292 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
2br1 | PFP | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.450 | |
2iw8 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.450 | |
2vtt | LZD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
2wpa | 889 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
2xb7 | GUI | ALK tyrosine kinase receptor | 2.7.10.1 | 0.450 | |
2z97 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.450 | |
3bhh | 5CP | Calcium/calmodulin-dependent protein kinase type II subunit beta | 2.7.11.17 | 0.450 | |
3fzr | 3JZ | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.450 | |
3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.450 | |
4hyu | 1BK | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.450 | |
4iva | 1J5 | Tyrosine-protein kinase JAK2 | / | 0.450 | |
1m2p | HNA | Casein kinase II subunit alpha | 2.7.11.1 | 0.449 | |
1oir | HDY | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
1uu8 | BI1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.449 | |
2brm | DFZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.449 | |
2f7e | 2EA | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.449 | |
2pvj | P44 | Casein kinase II subunit alpha | 2.7.11.1 | 0.449 | |
2uzb | C75 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
3nga | 3NG | Casein kinase II subunit alpha | 2.7.11.1 | 0.449 | |
3pxk | PXK | Focal adhesion kinase 1 | 2.7.10.2 | 0.449 | |
4dta | ADN | APH(2'')-Id | / | 0.449 | |
4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.449 | |
5e92 | ANP | TGF-beta receptor type-2 | 2.7.11.30 | 0.449 | |
1jkl | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.448 | |
1oit | HDT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
1rfu | ADP | Pyridoxal kinase | 2.7.1.35 | 0.448 | |
1uu7 | BI2 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.448 | |
1xr1 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.448 | |
2ds1 | 1CD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.448 | |
2q9f | C3S | Cholesterol 24-hydroxylase | / | 0.448 | |
2r3k | SCQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
2x2k | X2K | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.448 | |
3ama | SKE | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.448 | |
3ddq | RRC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
3dfc | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.448 | |
3hmm | 855 | TGF-beta receptor type-1 | 2.7.11.30 | 0.448 | |
3qzg | X67 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
4cp4 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.448 | |
4qmp | DKI | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.448 | |
4ysj | ADP | Calmodulin-like domain protein kinase | / | 0.448 | |
1day | GNP | Casein kinase II subunit alpha | 2.7.11.1 | 0.447 | |
1fin | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
1nxk | STU | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.447 | |
2wmt | ZYT | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
2yaa | ATP | Death-associated protein kinase 2 | / | 0.447 | |
3i60 | E86 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.447 | |
3lcd | BDY | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.447 | |
3lit | E15 | Protease | / | 0.447 | |
3qtu | X44 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
3r1q | X75 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.447 | |
4f4p | 0SB | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.447 | |
4fkl | CK2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
4foc | 0UU | ALK tyrosine kinase receptor | 2.7.10.1 | 0.447 | |
4ft9 | H4K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
4lrj | ANP | Uncharacterized protein | / | 0.447 | |
1f4f | TP3 | Thymidylate synthase | / | 0.446 | |
1q4u | 4CA | 4-hydroxybenzoyl-CoA thioesterase | 3.1.2.23 | 0.446 | |
1q97 | ATP | Serine/threonine-protein kinase SKY1 | 2.7.11.1 | 0.446 | |
1wvy | STU | Death-associated protein kinase 1 | 2.7.11.1 | 0.446 | |
2bhe | BRY | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
2hy0 | 306 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
2ojj | 82A | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.446 | |
2ozo | ANP | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.446 | |
2uw6 | GVO | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.446 | |
2ym7 | YM7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
3ork | AGS | Serine/threonine protein kinase | / | 0.446 | |
3rk7 | 08Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
3sqq | 99Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
3vf8 | 0JE | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.446 | |
4fl3 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.446 | |
4fx3 | 60K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
4qo9 | 627 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.446 | |
4riy | ANP | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.446 | |
5dpv | SKE | Aurora kinase A | 2.7.11.1 | 0.446 | |
2wmu | ZYU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
2y9q | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.445 | |
3lfn | A27 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
3qd0 | 3Q4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.445 | |
3r8l | Z30 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
3s2a | 2NQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.445 | |
3uzp | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.445 | |
4eok | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
4f08 | 1RS | Tyrosine-protein kinase JAK2 | / | 0.445 | |
4fkv | 61K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
4jbp | YPH | Aurora kinase A | 2.7.11.1 | 0.445 | |
4kba | 1QM | Casein kinase I isoform delta | 2.7.11.1 | 0.445 | |
4n57 | ADP | APH(2'')-Id | / | 0.445 | |
5aac | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.445 | |
5cvf | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.445 | |
1bvr | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.444 | |
1nvs | UCM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
1q99 | ANP | Serine/threonine-protein kinase SKY1 | 2.7.11.1 | 0.444 | |
1t88 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.444 | |
2a4l | RRC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
2bmc | MPY | Aurora kinase A | 2.7.11.1 | 0.444 | |
2cpp | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.444 | |
2jds | L20 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.444 | |
2o65 | MYF | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.444 | |
2vtn | LZ7 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
2xrw | ANP | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.444 | |
3el5 | 1UN | Gag-Pol polyprotein | / | 0.444 | |
3fwi | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.444 | |
3sd0 | TSK | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.444 | |
4btj | ADP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.444 | |
4dym | IYZ | Activin receptor type-1 | 2.7.11.30 | 0.444 | |
4f9w | LM4 | Mitogen-activated protein kinase 14 | / | 0.444 | |
4fkj | 11K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
5cu6 | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.444 | |
1oiu | N76 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
1pxp | CK8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
1q3d | STU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.443 | |
1yw2 | PGJ | Mitogen-activated protein kinase 14 | / | 0.443 | |
2aqi | NAI | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.443 | |
2aqk | NAI | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.443 | |
2b53 | D23 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
2f7x | 4EA | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.443 | |
2k62 | ITL | Fatty acid-binding protein, liver | / | 0.443 | |
2ojf | 4PY | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.443 | |
2r3j | SCJ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
2uzn | C96 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
2y7j | B49 | Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | 2.7.11.19 | 0.443 | |
3c0g | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.443 | |
3c50 | ADP | Rhodopsin kinase | / | 0.443 | |
3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.443 | |
3orp | AGS | Serine/threonine protein kinase | / | 0.443 | |
3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.443 | |
3u9e | COA | Lmo1369 protein | / | 0.443 | |
4iwd | 1JC | Hepatocyte growth factor receptor | 2.7.10.1 | 0.443 | |
4mf1 | 29Y | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.443 | |
4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.443 | |
4oa9 | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.443 | |
5cp4 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.443 | |
1noo | CAH | Camphor 5-monooxygenase | 1.14.15.1 | 0.442 | |
1ogu | ST8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
2c6k | DT2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
2gnh | H52 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.442 | |
2ijm | ATP | Focal adhesion kinase 1 | 2.7.10.2 | 0.442 | |
3bht | MFR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
3biz | 61E | Wee1-like protein kinase | 2.7.10.2 | 0.442 | |
3bkb | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.442 | |
3mfr | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.442 | |
3qrt | X14 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
3rk9 | 09Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
4c9p | CAM | Cytochrome P450 | / | 0.442 | |
4fkr | 45K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
4fod | 0UV | ALK tyrosine kinase receptor | 2.7.10.1 | 0.442 | |
4ftc | H6K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
4ii5 | ADP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
4j98 | ACP | Fibroblast growth factor receptor 2 | / | 0.442 | |
4kz0 | 1UJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.442 | |
5auz | GEN | Death-associated protein kinase 1 | 2.7.11.1 | 0.442 | |
1iwj | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.441 | |
1pxm | CK5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
1uyu | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.441 | |
2c6m | DT5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
2chx | 090 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.441 | |
2j2i | LY4 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.441 | |
2j9m | PY8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
2p5u | NAD | UDP-glucose 4-epimerase | / | 0.441 | |
2r3p | 3SC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
2vo6 | M05 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.441 | |
2wtj | WTJ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.441 | |
3fzp | AGS | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.441 | |
3liv | E16 | Protease | / | 0.441 | |
3nie | ANP | Mitogen-activated protein kinase | / | 0.441 | |
3nuy | JPZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.441 | |
3q3b | 55E | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.441 | |
3ral | 04Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.441 | |
3sw4 | 18K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
3w55 | 1FM | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.441 | |
4ach | KDI | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.441 | |
4c61 | LMM | Tyrosine-protein kinase JAK2 | / | 0.441 | |
4e4m | 0NH | Tyrosine-protein kinase JAK2 | / | 0.441 | |
4fv8 | E63 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.441 | |
4fyo | 0VF | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.441 | |
4j1r | I5R | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.441 | |
5aab | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.441 | |
1ir3 | ANP | Insulin receptor | 2.7.10.1 | 0.440 | |
1pjk | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 | |
1yi3 | LY2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.440 | |
1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.440 | |
2b55 | D31 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
2brb | PFQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
2hxq | 373 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
2qhn | 582 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.440 | |
3qc9 | ADP | Rhodopsin kinase | / | 0.440 | |
3qtx | X43 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
3s1h | 56Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
4ek8 | 16K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
4ez3 | 0S0 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
4fkp | LS5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
4fz7 | 0VH | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.440 | |
4ivb | 1J5 | Tyrosine-protein kinase JAK1 | / | 0.440 | |
4mf0 | 29Z | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.440 |